A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain
Terminated
PriCara, Unit of Ortho-McNeil, Inc.
Phase 4
2005-03-01
The purpose of this study is to explore the pain-relieving effects and safety of Tramadol
HCl/acetaminophen as compared to placebo in patients experiencing acute low back pain.
Tramadol HCl/acetaminophen is approved for short-term management of acute pain. The
combination of tramadol HCl/acetaminophen has been shown to be effective for the treatment of
acute musculoskeletal pain. Patients who experienced at least moderate acute low back pain
for 2 to 10 days before study entry will be randomized to receive either tramadol
HCl/acetaminophen or placebo.
A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain
Terminated
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4
2005-03-01
The purpose of this study is to explore the pain-relieving effects and safety of Tramadol
HCl/acetaminophen as compared to placebo in patients experiencing acute low back pain.
Tramadol HCl/acetaminophen is approved for short-term management of acute pain. The
combination of tramadol HCl/acetaminophen has been shown to be effective for the treatment of
acute musculoskeletal pain. Patients who experienced at least moderate acute low back pain
for 2 to 10 days before study entry will be randomized to receive either tramadol
HCl/acetaminophen or placebo.
A Comparison of the Effectiveness and Safety of ULTRACETĀ® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAMĀ® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery
Completed
PriCara, Unit of Ortho-McNeil, Inc.
Phase 4
2002-11-01
The purpose of this study is to explore the pain-relieving effects and safety of two
analgesic treatment regimens as compared to placebo in patients experiencing pain after oral
surgery. Tramadol hydrochloride/acetaminophen is approved to treat acute pain. This study
will evaluate the effectiveness and safety of tramadol hydrochloride/acetaminophen compared
with tramadol hydrochloride alone compared with placebo as a pain medication in the treatment
of pain following oral surgery.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.